CTAG2 Antibody (Center) Blocking peptide
€363.00
In stock
SKU
AC-BP13767c
Background:
This gene encodes an autoimmunogenic tumor antigen thatbelongs to the ESO/LAGE family of cancer-testis antigens. Thisprotein is expressed in a wide array of cancers including melanoma,breast cancer, bladder cancer and prostate cancer. This protein isalso expressed in normal testis tissue. An alternative open readingframe product of this gene has been described in PMID 10399963.This alternate protein, termed CAMEL, is a tumor antigen that isrecognized by melanoma-specific cytotoxic T-lymphocytes. Alternatesplicing results in multiple transcript variants. [provided byRefSeq].
Other Names:
Cancer/testis antigen 2, CT2, Autoimmunogenic cancer/testis antigen NY-ESO-2, Cancer/testis antigen 62, CT62, L antigen family member 1, LAGE-1, CTAG2, ESO2, LAGE1
Target/Specificity:
The synthetic peptide sequence used to generate the antibody AP13767c was selected from the Center region of CTAG2. A 10 to 100 fold molar excess to antibody is recommended. Precise conditions should be optimized for a particular assay.
Gene Name: CTAG2
Gene ID: 30848
Primary Accession: O75638
Format: Peptides are lyophilized in a solid powder format. Peptides can be reconstituted in solution using the appropriate buffer as needed.
This gene encodes an autoimmunogenic tumor antigen thatbelongs to the ESO/LAGE family of cancer-testis antigens. Thisprotein is expressed in a wide array of cancers including melanoma,breast cancer, bladder cancer and prostate cancer. This protein isalso expressed in normal testis tissue. An alternative open readingframe product of this gene has been described in PMID 10399963.This alternate protein, termed CAMEL, is a tumor antigen that isrecognized by melanoma-specific cytotoxic T-lymphocytes. Alternatesplicing results in multiple transcript variants. [provided byRefSeq].
Other Names:
Cancer/testis antigen 2, CT2, Autoimmunogenic cancer/testis antigen NY-ESO-2, Cancer/testis antigen 62, CT62, L antigen family member 1, LAGE-1, CTAG2, ESO2, LAGE1
Target/Specificity:
The synthetic peptide sequence used to generate the antibody AP13767c was selected from the Center region of CTAG2. A 10 to 100 fold molar excess to antibody is recommended. Precise conditions should be optimized for a particular assay.
Gene Name: CTAG2
Gene ID: 30848
Primary Accession: O75638
Format: Peptides are lyophilized in a solid powder format. Peptides can be reconstituted in solution using the appropriate buffer as needed.
| Is Featured? | No |
|---|
Write Your Own Review